Zura Bio Limited
ZURA
$1.23
$0.086.96%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/8/2025
-
MarketBeat
4/5/2025
-
MarketBeat
4/4/2025
-
Ticker Report
4/3/2025
-
TipRanks Financial Blog
4/3/2025
-
The Fly
4/2/2025
-
Simply Wall St
3/30/2025
-
TipRanks Financial Blog
3/29/2025
-
MarketBeat
3/29/2025
-
MarketBeat
3/28/2025
-
MarketBeat
3/27/2025
-
MarketBeat
3/27/2025
-
MarketBeat
3/26/2025
-
The Fly
3/25/2025
-
GuruFocus
3/25/2025
-
Business Wire
3/20/2025
-
MarketBeat
3/10/2025
-
MarketBeat
2/24/2025
-
GuruFocus
2/24/2025
-
Business Wire
2/15/2025
-
GuruFocus
2/15/2025
-
GuruFocus
2/14/2025
-
MarketBeat
2/3/2025
-
Simply Wall St
1/28/2025
-
Ticker Report
1/24/2025
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
702 825 9872
Address
1489 W. Warm Springs Road
Henderson, NV 89014
Henderson, NV 89014
Country
Year Founded
Business Description
Sector
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. The company develops Tibulizumab, an immunoglobulin...
more